MdxHealth (TM) : MDxHealth's new share capital amount and number of shares LIEGE, BELGIUM - July 2, 2013 - MDxHealth SA (NYSE Euronext : MDXH), in conformity with article 15 of the Law of May 2, 2007 on the publication of significant shareholdings in issuers which shares are admitted to trading on a regulated market, and further to the capital increase having taken place on Tuesday, June 25, 2013, MDxHealth publishes that its share capital has increased from EUR 20,351,568.70 to EUR 27,321,762.02 and that its issued and outstanding shares have increased from 25,513,440 to 34,251,303, through the issuance of 8,737,863 new shares. About MDxHealth^® MDxHealth is a molecular diagnostics company that develops and commercializes advanced epigenetic tests for cancer assessment and the personalized treatment of patients. The company's first commercial product, ConfirmMDx^TM for Prostate Cancer, has been shown to help distinguish patients who have a true-negative biopsy from those who may have undetected cancer. MDxHealth helps to address a large and growing unmet medical need for better cancer diagnosis and treatment information. The company has a proprietary platform and a strong epigenetic product pipeline focused on the development of products for prostate, brain and lung cancers. The company is based in Irvine, California with a European headquarters in Liege, Belgium. For more information visit MDxHealth's website at www.mdxhealth.com. For more information: Mike Sinclair Dr. Jan Groen, CEO Halsin Partners MDxHealth UK: +44 20 7318 2955 US: +1 949 812 6979 Cell: +44 7968 022075 BE: +32 4 364 20 70 firstname.lastname@example.org email@example.com Important notice NOTE: The MDxHealth logo, MDxHealth, ConfirmMDx and PredictMDx are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners. To access the PDF version, please click here ------------------------------------------------------------------------------ This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: MdxHealth (TM) via Thomson Reuters ONE HUG#1713596
MdxHealth (TM) : MDxHealth's new share capital amount and number of shares
Press spacebar to pause and continue. Press esc to stop.